Combination therapy with Amaryl and insulin may also be used in secondary failure patients. The fasting glucose level for instituting combination therapy is in the range of >150 mg/dL in plasma or serum depending on the patient. The recommended Amaryl dose is 8 mg once daily administered with the first main meal. After starting with low-dose insulin, upward adjustments of insulin can be done approximately weekly as guided by frequent measurements of fasting blood glucose. Once stable, combination-therapy patients should monitor their capillary blood glucose on an ongoing basis, preferably daily. Periodic adjustments of insulin may also be necessary during maintenance as guided by glucose and HbA1clevels.
Most important information about Amaryl
More information about AMARYL (Glimepiride):
Amaryl-Metformin Combination Therapy
To buy Amaryl click HERE: My Family Drugstore
Tags: Amaryl (Glimepiride), Conditions & Treatments, Medications, Type 2 Diabetes